Lecture 6 Flashcards

1
Q

T or F: prescribing PN independently is an entry-level competency

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PN used for people with:

A

non functional GI tract, unable meet nutr rqts with PO/EN, inadequate PO/EN for prolonged period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

symptoms of non functional GI:

A

significant malabsorption, bowel obstruction, prolonged ileus, GI ischemia, intractable vomiting, GI fistula, GI bleed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

contraindications for PN:

A

functioning GI, anticipated duration only <7days, prognosis in which goals of care don’t warrant aggressive nutr support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 routes of PN infusion?

A

peripheral (terminate in small diameter vein), central (terminate in large diameter vein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

most common PN in Sask?

A

PICC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

factors influencing choice of PN:

A

anticipated duration, osmolarity of solution, energy requirements, fluid tolerance, central line contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

indicators for PPN:

A

short term period of PN (up to 14 days), pt reasonably nourished, have peripheral vein access, catheritization of central vein is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PPN contraindications:

A

large cal/nutr/electrolyte needs (max solution osmolarity is 900 mOsm/L), fluid restriction, need for prolonged PN, renal/liver compromise, severe metabolic stress, poor peripheral vein access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

complications of PPN:

A

phlebitis (inflammation of a vein), thrombosis, pain, infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

advantages of PPN:

A

relatively easy venous access, decreased complications/infections risk (BUT have to change IV site often to maintain vein patency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

indications for CPN:

A

PN >14 days, can accommodate hyperosmolar solution, easier to maintain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why can CPN handle hypertonic solution?

A

high blood flow and volume of blood present rapidly dilutes hypertonic solution so doesn’t damage BV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

form of protein in PN:

A

crystalline a a (3.5-20% protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

a a products typically assumed to be __% Nitrogen

A

16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nitrogen balance = _________

A

(protein intake g/d / 6.25) - (UUN g/d + 4 g/d)

17
Q

dextrose monohydrate has ___ kcal/g

18
Q

available concentrations of dextrose:

19
Q

max concentration dextrose for PPN is:

20
Q

why not >10% dextrose in PPN?

A

thrombophlebitis

21
Q

max oxidative rate for CHO is ___, minimum required for pro sparing is ____

A

4-5 mg/kg/min; 1 mg/kg/min

22
Q

why max oxidative rate for CHO?

A

excess cause hyperglycemia, hepatic abnormalities, excess CO2 production/ventilatory drive, overfeeding

23
Q

dual role of lipid:

A

source of non protein energy, source of EFA

24
Q

PN lipid emulsions available in these 3 concentrations:

A

10%, 20%, 30%

25
1st gen lipid emulsions:
intralipid, high in n-6 fa
26
2nd gen lipid emulsions:
balanced blends of n-3, n-6, n-9; anti-inflammatory, improved outcomes for septic pt and reduced PN associated liver disease
27
minimum amount of fat to prevent EFA deficiency is:
8-10% energy, which is 500mL (100g/week) intralipid weekly
28
when would you need to restrict amount of fat?
hypertriglyceridemia
29
typical adult dosing for lipid:
25-30% energy, max 1-1.5 g /kg/day, infusion rate not to exceed 0.11 g /kg/h
30
is 3-in-1 or 2-in-1 more flexible?
2-in-1
31
most common PN deficiencies:
linoleic acid, zinc, copper, selenium, fat/water soluble vits, chromium
32
how to prevent and treat liver steatosis?
decrease CHO intake, avoid hyperalimentation, use cyclical PN
33
how to prevent and treat PNALD?
stim intestine, prevent bacterial overgrowth, taurine, ursodeoxycholic acid, cholecystokinin, vit E
34
2 emphasized acute deficiencies:
hypoglycemia, hypophosphatemia
35
liver steatosis is associated with:
^ plasma aminotransferases and liver enlargement (overfeeding, esp gluc)
36
cholestatic liver disease is more common in:
kids and neonates
37
most severe PN complications:
cholestatic liver disease, metabolic bone disease